Type a term, then click a field below.

Search | advanced search

keepers


Type a term, then click a field below.

Search | simple search





1 subtopic

 

  • Omeprazole

2-PyridinylmethylsulfinylbenzimidazolesFollow by RSS 

You've reached a pubget topic page. Below are the latest papers on this topic, with subtopics on the left.

keywords > Organic Chemicals > Sulfur Compounds > Sulfoxides > 2-Pyridinylmethylsulfinylbenzimidazoles

Latest papers

Influence of efflux pump inhibitors on the multidrug resistance of Helicobacter pylori.

Helicobacter pylori-negative gastritis in erosive esophagitis, nonerosive reflux disease or functional dyspepsia patients.

Comparison of 7- and 14-day first-line therapies including levofloxacin in patients with Helicobacter pylori positive non-ulcer dyspepsia.

The prognosis of patients having received optimal therapy for nonvariceal upper gastrointestinal bleeding might be worse in daily practice than in randomized clinical trials.

Effect of Helicobacter pylori eradication on insulin resistance, serum lipids and low-grade inflammation.

Inappropriate use of proton pump inhibitors.

Pharmacokinetics evaluation of soft agglomerates for prompt delivery of enteric pantoprazole-loaded microparticles

Dexlansoprazole for the treatment of esophagitis and GERD.

Generics offer pharmacy plans specific benefits.

Delayed release film coating applications on oral solid dosage forms of proton pump inhibitors: case studies.

Gastric emptying and electrogastrography in reflux esophagitis: results in patients showing endoscopically erosive esophagitis under proton pump inhibitor therapy.

[Case of suspicious lansoprazole-associated collagenous colitis in ANCA-associated nephritis]

Multiple congenital red-brown macules, thrombocytopenia, and gastrointestinal bleeding. Diagnosis: Multifocal lymphangioendotheliomatosis with thrombocytopenia (MLT).

Bioequivalence study of a fixed dose combination tablet containing rabeprazole and diclofenac sodium in healthy Indian subjects.

Costs and risks in the management of patients with gastric acid hypersecretion.

Liquid chromatography-tandem mass/mass spectrometry method for the quantification of rabeprazole in human plasma and application to a pharmacokinetic study.

Characteristics of symptomatic reflux episodes in patients with non-erosive reflux disease who have a positive symptom index on proton pump inhibitor therapy.

Evaluation of pantoprazole formulations in different dissolution apparatus using biorelevant medium.

Pharmacological dependency in chronic treatment of gastroesophageal reflux disease: a randomized controlled clinical trial.

Continuation of low-dose aspirin therapy in peptic ulcer bleeding: a randomized trial.

page 1 2 3 4 5 6 7 8 9 10 11 ...